Loading viewer...
investor_presentation
Format: PDF investor_presentation
Novo Nordisk presented Q1 2023 results and strategic aspirations at the ADA San Diego conference on June 25, 2023. The presentation highlights commercial execution with 25% sales growth, obesity care sales of DKK 7.8 billion, and innovation progress including regulatory submissions for diabetes and obesity treatments. The company emphasizes its commitment to reaching millions of diabetes patients worldwide while advancing sustainable operations and leadership diversity.
investor_presentation
13 Pages
Novo Nordisk Full Year 2020 Investor Presentation
investor_presentationinvestor_presentation
130 Pages
Novo Nordisk Full Year 2023 Investor Presentation
investor_presentationinvestor_presentation
163 Pages
investor_presentation
54 Pages
Power Integrations, Inc.
Adani Airports Holdings (AAHL) Investor Presentation 2022
investor_presentationinvestor_presentation
64 Pages
Adani Airports Holdings Limited
Tiger Logistics Q3 FY2023 Investor Presentation December 2022
investor_presentationinvestor_presentation
36 Pages
Tiger Logistics (India) Limited
investor_presentation
LifeMD